<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c956d-cba2-7819-ba14-3a52d574107b,g:cc6a57ef-7288-45a7-8578-69a4f6142a05-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.primemedicine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="prme-20260331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.primemedicine.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019c956d-cc59-733d-af50-8f5956b521ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019c956d-cc59-79af-a286-f82f6f17337b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019c956d-cc59-733d-af50-8f5956b521ca" xlink:to="loc_us-gaap_StockholdersEquity_019c956d-cc59-79af-a286-f82f6f17337b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019c956d-cc59-7ef3-bfb9-3788b9bfa3a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019c956d-cc59-733d-af50-8f5956b521ca" xlink:to="loc_us-gaap_Liabilities_019c956d-cc59-7ef3-bfb9-3788b9bfa3a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019c956d-cc59-70d5-aa4d-ecbd153b1144" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019c956d-cc59-733d-af50-8f5956b521ca" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019c956d-cc59-70d5-aa4d-ecbd153b1144" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019c956d-cc59-7031-a6dd-fb5fb5a84eae" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019c956d-cc59-7977-b2cb-d4bfe516564e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c956d-cc59-7031-a6dd-fb5fb5a84eae" xlink:to="loc_us-gaap_AssetsCurrent_019c956d-cc59-7977-b2cb-d4bfe516564e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019c956d-cc59-7821-ac1e-2a7c09a66ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c956d-cc59-7031-a6dd-fb5fb5a84eae" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019c956d-cc59-7821-ac1e-2a7c09a66ce3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019c956d-cc59-759f-8a4c-d5057b623a64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c956d-cc59-7031-a6dd-fb5fb5a84eae" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019c956d-cc59-759f-8a4c-d5057b623a64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_019c956d-cc59-7c78-bbc6-c3fd36010b76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c956d-cc59-7031-a6dd-fb5fb5a84eae" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_019c956d-cc59-7c78-bbc6-c3fd36010b76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019dd240-6253-7c93-bb3e-9e4589887f48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019c956d-cc59-7031-a6dd-fb5fb5a84eae" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019dd240-6253-7c93-bb3e-9e4589887f48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019c956d-cc59-7c3d-8d8a-70b7743e0061" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019c956d-cc59-7a59-93f3-89774ce2493a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019c956d-cc59-7c3d-8d8a-70b7743e0061" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019c956d-cc59-7a59-93f3-89774ce2493a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019c956d-cc59-7d30-9ce7-54b631b3edf7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019c956d-cc59-7c3d-8d8a-70b7743e0061" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019c956d-cc59-7d30-9ce7-54b631b3edf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019c956d-cc59-70d3-8d61-7d81da391c73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019c956d-cc59-7c3d-8d8a-70b7743e0061" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019c956d-cc59-70d3-8d61-7d81da391c73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019c956d-cc59-7c3e-b725-5c6908889d07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019c956d-cc59-7c3d-8d8a-70b7743e0061" xlink:to="loc_us-gaap_CommonStockValue_019c956d-cc59-7c3e-b725-5c6908889d07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019c956d-cc59-76e9-9c77-cbd5f69d9edf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019c956d-cc59-75c7-8c19-211f3b7a9cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019c956d-cc59-76e9-9c77-cbd5f69d9edf" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019c956d-cc59-75c7-8c19-211f3b7a9cc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019c956d-cc59-7c5d-9145-4e1ccaf40314" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019c956d-cc59-76e9-9c77-cbd5f69d9edf" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019c956d-cc59-7c5d-9145-4e1ccaf40314" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019c956d-cc59-7e51-b001-8a81d5f03eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019c956d-cc59-76e9-9c77-cbd5f69d9edf" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019c956d-cc59-7e51-b001-8a81d5f03eb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019c956d-cc59-747e-ab53-ac6298b40419" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019c956d-cc59-76e9-9c77-cbd5f69d9edf" xlink:to="loc_us-gaap_AccountsPayableCurrent_019c956d-cc59-747e-ab53-ac6298b40419" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019c956d-cc59-7895-a687-130a55b357d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019c956d-cc59-7058-b59e-8bf2c809d15f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019c956d-cc59-7895-a687-130a55b357d7" xlink:to="loc_us-gaap_LiabilitiesCurrent_019c956d-cc59-7058-b59e-8bf2c809d15f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019c956d-cc59-7b2d-9b79-90bdc86a8add" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019c956d-cc59-7895-a687-130a55b357d7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_019c956d-cc59-7b2d-9b79-90bdc86a8add" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019c956d-cc59-7f2d-b9b8-c335f248a7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019c956d-cc59-7895-a687-130a55b357d7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_019c956d-cc59-7f2d-b9b8-c335f248a7f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prme_ResearchAndDevelopmentFundingLiabilityNoncurrent_019c956d-cc59-7be5-b546-6525c1509372" xlink:href="prme-20260331.xsd#prme_ResearchAndDevelopmentFundingLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019c956d-cc59-7895-a687-130a55b357d7" xlink:to="loc_prme_ResearchAndDevelopmentFundingLiabilityNoncurrent_019c956d-cc59-7be5-b546-6525c1509372" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019c956d-cc59-7b94-81f3-32199d64198b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_019c956d-cc59-743a-adb3-a099d23d7e23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019c956d-cc59-7b94-81f3-32199d64198b" xlink:to="loc_us-gaap_OtherAssetsCurrent_019c956d-cc59-743a-adb3-a099d23d7e23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019c956d-cc59-78f6-859a-4cfb91b0dfc8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019c956d-cc59-7b94-81f3-32199d64198b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019c956d-cc59-78f6-859a-4cfb91b0dfc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019c956d-cc59-7b93-9570-0e40fcd1756a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019c956d-cc59-7b94-81f3-32199d64198b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019c956d-cc59-7b93-9570-0e40fcd1756a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_019c956d-cc59-7043-9c9e-17336b29cdc5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019c956d-cc59-7b94-81f3-32199d64198b" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_019c956d-cc59-7043-9c9e-17336b29cdc5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.primemedicine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="prme-20260331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.primemedicine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_019c956d-cc59-7a7f-b0af-78df7c9a1679" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019c956d-cc59-7d49-bffe-03bcf44ecec8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_019c956d-cc59-7a7f-b0af-78df7c9a1679" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019c956d-cc59-7d49-bffe-03bcf44ecec8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019c956d-cc59-7f0e-bbad-2109a15dae90" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019c956d-cc59-7b46-80c7-895bc39b9d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019c956d-cc59-7f0e-bbad-2109a15dae90" xlink:to="loc_us-gaap_OperatingExpenses_019c956d-cc59-7b46-80c7-895bc39b9d7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c956d-cc59-74cd-99c9-d02af7f7b470" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019c956d-cc59-7f0e-bbad-2109a15dae90" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c956d-cc59-74cd-99c9-d02af7f7b470" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019c956d-cc59-7620-9bb9-9ab18d92d74e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_prme_ChangeInFairValueOfShortTermInvestment_019c956d-cc59-73a1-90ff-0b5265f8604b" xlink:href="prme-20260331.xsd#prme_ChangeInFairValueOfShortTermInvestment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019c956d-cc59-7620-9bb9-9ab18d92d74e" xlink:to="loc_prme_ChangeInFairValueOfShortTermInvestment_019c956d-cc59-73a1-90ff-0b5265f8604b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019c956d-cc59-7749-9ddd-c2935085381a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019c956d-cc59-7620-9bb9-9ab18d92d74e" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019c956d-cc59-7749-9ddd-c2935085381a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019c956d-cc59-7038-b73a-1284b10f8671" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019c956d-cc59-7620-9bb9-9ab18d92d74e" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019c956d-cc59-7038-b73a-1284b10f8671" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019c956d-cc59-7d3e-aff5-61de9701b9dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019c956d-cc59-7620-9bb9-9ab18d92d74e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019c956d-cc59-7d3e-aff5-61de9701b9dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019c956d-cc59-7409-9803-3775b0464273" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_019c956d-cc59-7d10-9d65-d84ba181f8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019c956d-cc59-7409-9803-3775b0464273" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_019c956d-cc59-7d10-9d65-d84ba181f8d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c956d-cc59-747f-a4c3-11fe9b3761aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019c956d-cc59-7409-9803-3775b0464273" xlink:to="loc_us-gaap_NetIncomeLoss_019c956d-cc59-747f-a4c3-11fe9b3761aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019c956d-cc59-7a22-866b-5cbb7955b2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019c956d-cc59-7b76-af00-8510d9970d21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019c956d-cc59-7a22-866b-5cbb7955b2ee" xlink:to="loc_us-gaap_OperatingIncomeLoss_019c956d-cc59-7b76-af00-8510d9970d21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019c956d-cc59-7edc-a87a-fe772d2b7240" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_019c956d-cc59-7a22-866b-5cbb7955b2ee" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019c956d-cc59-7edc-a87a-fe772d2b7240" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019c956d-cc59-7074-89d7-59f95ed71f31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019c956d-cc59-748c-9dc1-3b2caefa28a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019c956d-cc59-7074-89d7-59f95ed71f31" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019c956d-cc59-748c-9dc1-3b2caefa28a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019c956d-cc59-7308-93ea-c69d57f9f255" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019c956d-cc59-7074-89d7-59f95ed71f31" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019c956d-cc59-7308-93ea-c69d57f9f255" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.primemedicine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="prme-20260331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.primemedicine.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_prme_AccretionAmortizationOfDiscountsAndPremiumsShortTermInvestments_019c956d-cc5a-7757-a2d0-6493ee59b7e3" xlink:href="prme-20260331.xsd#prme_AccretionAmortizationOfDiscountsAndPremiumsShortTermInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:to="loc_prme_AccretionAmortizationOfDiscountsAndPremiumsShortTermInvestments_019c956d-cc5a-7757-a2d0-6493ee59b7e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019c956d-cc5a-7f7b-a75c-33b2ab644a99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019c956d-cc5a-7f7b-a75c-33b2ab644a99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019c956d-cc5a-764b-b295-1248ad29780d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_019c956d-cc5a-764b-b295-1248ad29780d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019c956d-cc5a-778b-9dc9-e3b635383f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_019c956d-cc5a-778b-9dc9-e3b635383f9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_019c956d-cc5a-735d-a1a1-d9ecc805b0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_019c956d-cc5a-735d-a1a1-d9ecc805b0fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019c956d-cc5a-7eed-a7f2-2f9c6ac5f9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019c956d-cc5a-7eed-a7f2-2f9c6ac5f9b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019c956d-cc5a-7575-a11c-e3e430819316" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019c956d-cc5a-7575-a11c-e3e430819316" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019c956d-cc5a-7559-808e-307994f68f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_019c956d-cc5a-7559-808e-307994f68f6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c956d-cc5a-7f84-99aa-4c727ff348e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:to="loc_us-gaap_NetIncomeLoss_019c956d-cc5a-7f84-99aa-4c727ff348e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019c956d-cc5a-79a7-866b-0164e97d33d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019c956d-cc5a-79a7-866b-0164e97d33d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019c956d-cc5a-77c8-af90-a237a23e5195" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019c956d-cc5a-77c8-af90-a237a23e5195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019c956d-cc5a-7059-bef0-79e6b8f4c032" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7f1d-8dfb-6badbeea649d" xlink:to="loc_us-gaap_ShareBasedCompensation_019c956d-cc5a-7059-bef0-79e6b8f4c032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c956d-cc5a-719c-919a-1f010f01c261" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_019c956d-cc5a-74de-b704-ee4a59d88a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c956d-cc5a-719c-919a-1f010f01c261" xlink:to="loc_us-gaap_RestrictedCash_019c956d-cc5a-74de-b704-ee4a59d88a7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019c956d-cc5a-7283-a84f-0b9c632756d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019c956d-cc5a-719c-919a-1f010f01c261" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_019c956d-cc5a-7283-a84f-0b9c632756d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c956d-cc5a-73f5-8db7-d3dc4e7ebcd1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019c956d-cc5a-76cc-b24e-be5ed057b664" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c956d-cc5a-73f5-8db7-d3dc4e7ebcd1" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019c956d-cc5a-76cc-b24e-be5ed057b664" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prme_ProceedsFromResearchAndDevelopmentFundingLiability_019c956d-cc5a-7f62-bd9e-cba784f57983" xlink:href="prme-20260331.xsd#prme_ProceedsFromResearchAndDevelopmentFundingLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c956d-cc5a-73f5-8db7-d3dc4e7ebcd1" xlink:to="loc_prme_ProceedsFromResearchAndDevelopmentFundingLiability_019c956d-cc5a-7f62-bd9e-cba784f57983" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c956d-cc5a-744c-9d3c-d587d2fb173e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_019c956d-cc5a-720c-a479-34c33808c9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c956d-cc5a-744c-9d3c-d587d2fb173e" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_019c956d-cc5a-720c-a479-34c33808c9b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_019c956d-cc5a-7066-b3b5-edbc65b116be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c956d-cc5a-744c-9d3c-d587d2fb173e" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_019c956d-cc5a-7066-b3b5-edbc65b116be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019c956d-cc5a-736d-af15-336a815230eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c956d-cc5a-744c-9d3c-d587d2fb173e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019c956d-cc5a-736d-af15-336a815230eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019c956d-cc5a-7bc3-a347-eed46d7f5bce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7bfa-bb3f-8ca594b70133" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019c956d-cc5a-7bc3-a347-eed46d7f5bce" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019c956d-cc5a-7bfa-bb3f-8ca594b70133" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c956d-cc5a-7b9d-be58-aa2287b87109" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019c956d-cc5a-7bc3-a347-eed46d7f5bce" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019c956d-cc5a-7b9d-be58-aa2287b87109" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c956d-cc5a-771e-9cb3-18dcb0e85e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019c956d-cc5a-7bc3-a347-eed46d7f5bce" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019c956d-cc5a-771e-9cb3-18dcb0e85e1c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.primemedicine.com/role/SummaryofSignificantAccountingPoliciesScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="prme-20260331.xsd#SummaryofSignificantAccountingPoliciesScheduleofSegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.primemedicine.com/role/SummaryofSignificantAccountingPoliciesScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019c956d-cc5a-73e4-b291-824a16ebf952" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019c956d-cc5a-7179-9f22-f16bc3dc7d79" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019c956d-cc5a-73e4-b291-824a16ebf952" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019c956d-cc5a-7179-9f22-f16bc3dc7d79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c956d-cc5a-7114-b86b-c4cbe05965a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019c956d-cc5a-73e4-b291-824a16ebf952" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019c956d-cc5a-7114-b86b-c4cbe05965a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019c956d-cc5a-7957-81e4-1006a67a0828" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019c956d-cc5a-73e4-b291-824a16ebf952" xlink:to="loc_us-gaap_OperatingExpenses_019c956d-cc5a-7957-81e4-1006a67a0828" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019c956d-cc5a-73be-8270-b25031a716eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_prme_GeneralAndAdministrativeExpensePersonnelExpenses_019c956d-cc5a-7f08-b116-c491c61337d9" xlink:href="prme-20260331.xsd#prme_GeneralAndAdministrativeExpensePersonnelExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019c956d-cc5a-73be-8270-b25031a716eb" xlink:to="loc_prme_GeneralAndAdministrativeExpensePersonnelExpenses_019c956d-cc5a-7f08-b116-c491c61337d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019c956d-cc5a-70a8-9bfc-6eadde032a21" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019c956d-cc5a-73be-8270-b25031a716eb" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019c956d-cc5a-70a8-9bfc-6eadde032a21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prme_ResearchAndDevelopmentExpenseFacilityCosts_019c956d-cc5a-7e3e-999f-f1ef322025ad" xlink:href="prme-20260331.xsd#prme_ResearchAndDevelopmentExpenseFacilityCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019c956d-cc5a-73be-8270-b25031a716eb" xlink:to="loc_prme_ResearchAndDevelopmentExpenseFacilityCosts_019c956d-cc5a-7e3e-999f-f1ef322025ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prme_ResearchAndDevelopmentExpenseResearchCosts_019c956d-cc5a-7b51-8cb2-2fd15f06d99a" xlink:href="prme-20260331.xsd#prme_ResearchAndDevelopmentExpenseResearchCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019c956d-cc5a-73be-8270-b25031a716eb" xlink:to="loc_prme_ResearchAndDevelopmentExpenseResearchCosts_019c956d-cc5a-7b51-8cb2-2fd15f06d99a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prme_ResearchAndDevelopmentExpensePersonnelExpenses_019c956d-cc5a-7ded-9b5b-de4a894fc5df" xlink:href="prme-20260331.xsd#prme_ResearchAndDevelopmentExpensePersonnelExpenses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019c956d-cc5a-73be-8270-b25031a716eb" xlink:to="loc_prme_ResearchAndDevelopmentExpensePersonnelExpenses_019c956d-cc5a-7ded-9b5b-de4a894fc5df" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.primemedicine.com/role/FairValueMeasurementsandInvestmentsScheduleofHierarchyForAssetsandLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:type="simple" xlink:href="prme-20260331.xsd#FairValueMeasurementsandInvestmentsScheduleofHierarchyForAssetsandLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.primemedicine.com/role/FairValueMeasurementsandInvestmentsScheduleofHierarchyForAssetsandLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019c956d-cc5a-74e6-bc22-5d40dfab35e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c956d-cc5a-7a10-a81b-b271ebd0c427" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019c956d-cc5a-74e6-bc22-5d40dfab35e4" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019c956d-cc5a-7a10-a81b-b271ebd0c427" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.primemedicine.com/role/FairValueMeasurementsandInvestmentsScheduleofShortTermInvestmentsDetails" xlink:type="simple" xlink:href="prme-20260331.xsd#FairValueMeasurementsandInvestmentsScheduleofShortTermInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.primemedicine.com/role/FairValueMeasurementsandInvestmentsScheduleofShortTermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019c956d-cc5a-7e56-82d3-f2e977f75e11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019c956d-cc5a-7ed2-ab7a-b9ac1b75a14f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019c956d-cc5a-7e56-82d3-f2e977f75e11" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019c956d-cc5a-7ed2-ab7a-b9ac1b75a14f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019c956d-cc5a-7cce-8692-4ab54d67ea40" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019c956d-cc5a-7e56-82d3-f2e977f75e11" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019c956d-cc5a-7cce-8692-4ab54d67ea40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019c956d-cc5a-7638-8a36-e7c33e2632cb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019c956d-cc5a-7e56-82d3-f2e977f75e11" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019c956d-cc5a-7638-8a36-e7c33e2632cb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.primemedicine.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="prme-20260331.xsd#PropertyandEquipmentNetScheduleofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.primemedicine.com/role/PropertyandEquipmentNetScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019c956d-cc5a-7700-9ec6-31d180a0de0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019c956d-cc5a-70d8-bcab-f0a347fb833d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_019c956d-cc5a-7700-9ec6-31d180a0de0e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_019c956d-cc5a-70d8-bcab-f0a347fb833d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_019c956d-cc5a-727b-be44-5345fbf3eeb3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_019c956d-cc5a-7700-9ec6-31d180a0de0e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_019c956d-cc5a-727b-be44-5345fbf3eeb3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.primemedicine.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="prme-20260331.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.primemedicine.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019c956d-cc5a-720f-9537-90a093f53f57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_prme_AccruedLicenseFeeCurrent_019c956d-cc5a-775a-b56b-9dc13440e7ff" xlink:href="prme-20260331.xsd#prme_AccruedLicenseFeeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019c956d-cc5a-720f-9537-90a093f53f57" xlink:to="loc_prme_AccruedLicenseFeeCurrent_019c956d-cc5a-775a-b56b-9dc13440e7ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019c956d-cc5a-75a0-aa67-2b19302be549" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019c956d-cc5a-720f-9537-90a093f53f57" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019c956d-cc5a-75a0-aa67-2b19302be549" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019c956d-cc5a-789a-8096-80640f42630f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019c956d-cc5a-720f-9537-90a093f53f57" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019c956d-cc5a-789a-8096-80640f42630f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prme_AccruedResearchAndClinicalCostsCurrent_019c956d-cc5a-7394-8b6b-b607f8215a7c" xlink:href="prme-20260331.xsd#prme_AccruedResearchAndClinicalCostsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019c956d-cc5a-720f-9537-90a093f53f57" xlink:to="loc_prme_AccruedResearchAndClinicalCostsCurrent_019c956d-cc5a-7394-8b6b-b607f8215a7c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.primemedicine.com/role/LeasesDetails" xlink:type="simple" xlink:href="prme-20260331.xsd#LeasesDetails"/>
  <link:calculationLink xlink:role="http://www.primemedicine.com/role/LeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019c956d-cc5a-7ade-9ac7-667ec66c72e4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019c956d-cc5a-7334-9385-6db9e9a1ad69" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019c956d-cc5a-7ade-9ac7-667ec66c72e4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_019c956d-cc5a-7334-9385-6db9e9a1ad69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_prme_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_019c956d-cc5a-7101-a0cf-c1c15a983acf" xlink:href="prme-20260331.xsd#prme_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019c956d-cc5a-7ade-9ac7-667ec66c72e4" xlink:to="loc_prme_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_019c956d-cc5a-7101-a0cf-c1c15a983acf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019c956d-cc5a-7916-a5c9-90c38eac7498" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019c956d-cc5a-7ade-9ac7-667ec66c72e4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019c956d-cc5a-7916-a5c9-90c38eac7498" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019c956d-cc5a-70bd-bf42-3f3a00cd0b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019c956d-cc5a-7ade-9ac7-667ec66c72e4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_019c956d-cc5a-70bd-bf42-3f3a00cd0b3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019c956d-cc5a-775c-b57e-5670fcd4cd18" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019c956d-cc5a-7ade-9ac7-667ec66c72e4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_019c956d-cc5a-775c-b57e-5670fcd4cd18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019c956d-cc5a-77e3-889e-19d604c239dd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019c956d-cc5a-7ade-9ac7-667ec66c72e4" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_019c956d-cc5a-77e3-889e-19d604c239dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.primemedicine.com/role/LeasesDetails_1" xlink:type="simple" xlink:href="prme-20260331.xsd#LeasesDetails_1"/>
  <link:calculationLink xlink:role="http://www.primemedicine.com/role/LeasesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019c956d-cc5a-7ab7-aa55-784f75e84741" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019c956d-cc5a-76b3-a8bf-8da6d27521e3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019c956d-cc5a-7ab7-aa55-784f75e84741" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_019c956d-cc5a-76b3-a8bf-8da6d27521e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_019c956d-cc5a-7211-8477-377381cf46a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_019c956d-cc5a-7ab7-aa55-784f75e84741" xlink:to="loc_us-gaap_OperatingLeaseLiability_019c956d-cc5a-7211-8477-377381cf46a8" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
